DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility

European Journal of Cancer

Volumn 75, Issue , 2017, Pages 299-307

  Ambatipudi, Srikant ^a   Horvath, Steve ^b   Perrier, Flavie ^a   Cuenin, Cyrille ^a   Hernandez Vargas, Hector ^a   Le Calvez Kelm, Florence ^a   Durand, Geoffroy ^a   Byrnes, Graham ^a   Ferrari, Pietro ^a   Bouaoun, Liacine ^a   Sklias, Athena ^a   Chajes, Véronique ^a   Overvad, Kim ^c   Severi, Gianluca ^d,e,f   Baglietto, Laura ^d,f   Clavel Chapelon, Françoise ^d   Kaaks, Rudolf ^g   Barrdahl, Myrto ^g   Boeing, Heiner ^h   Trichopoulou, Antonia ^i,j   Lagiou, Pagona ^i,j,k   Naska, Androniki ^i,j   Masala, Giovanna ^l   Agnoli, Claudia ^m   Polidoro, Silvia ^e   Tumino, Rosario ⁿ   Panico, Salvatore ^o   Dollé, Martijn ^p   Peeters, Petra H M ^q,r   Onland Moret, N Charlotte ^q   Sandanger, Torkjel M ^s   Nøst, Therese H ^s   Weiderpass Vainio, Elisabete ^s,t,u,v   Quirós, J Ramón ^w   Agudo, Antonio ^x   Rodriguez Barranco, Miguel ^y,z   Huerta Castaño, José María ^z,aa   Barricarte, Aurelio ^z,ab,ac   Fernández, Ander Matheu ^ad,ae   Travis, Ruth C ^af   Vineis, Paolo ^r   Muller, David C ^r   Riboli, Elio ^r   Gunter, Marc ^a   Romieu, Isabelle ^a   Herceg, Zdenko ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AARHUS UNIVERSITY   (Denmark)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Human Genetics Foundation (HuGeF)   (Italy)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

ⁱ HELLENIC HEALTH FOUNDATION   (Greece)

^j UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ CIVILE M P AREZZO HOSPITAL   (Italy)

^o UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^p NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^q UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^r IMPERIAL COLLEGE LONDON   (United Kingdom)

^s UNIVERSITY OF TROMSØ   (Norway)

^t CANCER REGISTRY OF NORWAY   (Norway)

^u KAROLINSKA INSTITUTE   (Sweden)

^v FOLKHÄLSAN RESEARCH CENTER   (Finland)

^w Environmental Health Unit   (Spain)

^x HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^y UNIVERSITY OF GRANADA   (Spain)

^z CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^aa DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^ab INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ac Instituto de Investigación Sanitaria de Navarra   (Spain)

^ad BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^ae BASQUE FOUNDATION FOR SCIENCE   (Spain)

^af UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Age acceleration; Biomarkers; Breast cancer; DNA methylation; Epigenomics; Prospective studies

Indexed keywords

CYTOSINE; DNA; ESTROGEN RECEPTOR; GUANINE; PHOSPHATE; PROGESTERONE RECEPTOR;

ADULT; AGE DETERMINATION; AGING; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER SUSCEPTIBILITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GRANULOCYTE; HORMONE SUBSTITUTION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATURAL KILLER CELL; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGE; AGED; BREAST TUMOR; CASE CONTROL STUDY; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POSTMENOPAUSE;

EID: 85014082011     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2017.01.014     Document Type: Article

References (46)

1. [1] Benz, C.C., Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol 66:1 (2008), 65–74.
2. [2] Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348:6237 (2015), 880–886.
3. [3] Deelen, J., Beekman, M., Capri, M., Franceschi, C., Slagboom, P.E., Identifying the genomic determinants of aging and longevity in human population studies: progress and challenges. Bioessays 35:4 (2013), 386–396.
4. [4] Horvath, S., DNA methylation age of human tissues and cell types. Genome Biol, 14(10), 2013, R115.
5. [5] Marioni, R.E., Shah, S., McRae, A.F., Ritchie, S.J., Muniz-Terrera, G., Harris, S.E., et al. The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936. Int J Epidemiol 44:4 (2015), 1388–1396.
6. [6] Christiansen, L., Lenart, A., Tan, Q., Vaupel, J.W., Aviv, A., McGue, M., et al. DNA methylation age is associated with mortality in a longitudinal Danish twin study. Aging Cell 15:1 (2016), 149–154.
7. [7] Perna, L., Zhang, Y., Mons, U., Holleczek, B., Saum, K.U., Brenner, H., Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort. Clin Epigenetics, 8, 2016, 64.
8. [8] Horvath, S., Pirazzini, C., Bacalini, M.G., Gentilini, D., Di Blasio, A.M., Delledonne, M., et al. Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring. Aging (Albany NY) 7:12 (2015), 1159–1170.
9. [9] Chen, B.H., Marioni, R.E., Colicino, E., Peters, M.J., Ward-Caviness, C.K., Tsai, P.C., et al. DNA methylation-based measures of biological age: meta-analysis predicting time to death. Aging (Albany NY) 8:9 (2016), 1844–1865.
10. [10] Breitling, L.P., Saum, K.U., Perna, L., Schottker, B., Holleczek, B., Brenner, H., Frailty is associated with the epigenetic clock but not with telomere length in a German cohort. Clin Epigenetics, 8, 2016, 21.
11. [11] Levine, M.E., Lu, A.T., Bennett, D.A., Horvath, S., Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning. Aging (Albany NY) 7:12 (2015), 1198–1211.
12. [12] Simpkin, A.J., Hemani, G., Suderman, M., Gaunt, T.R., Lyttleton, O., McArdle, W.L., et al. Prenatal and early life influences on epigenetic age in children: a study of mother–offspring pairs from two cohort studies. Hum Mol Genet 25:1 (2016), 191–201.
13. [13] Horvath, S., Garagnani, P., Bacalini, M.G., Pirazzini, C., Salvioli, S., Gentilini, D., et al. Accelerated epigenetic aging in Down syndrome. Aging Cell 14:3 (2015), 491–495.
14. [14] Horvath, S., Levine, A.J., HIV-1 infection accelerates age according to the epigenetic clock. J Infect Dis 212:10 (2015), 1563–1573.
15. [15] Horvath, S., Langfelder, P., Kwak, S., Aaronson, J., Rosinski, J., Vogt, T.F., et al. Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels. Aging (Albany NY) 8:7 (2016), 1485–1512.
16. [16] Horvath, S., Erhart, W., Brosch, M., Ammerpohl, O., von Schonfels, W., Ahrens, M., et al. Obesity accelerates epigenetic aging of human liver. Proc Natl Acad Sci U S A 111:43 (2014), 15538–15543.
17. [17] Zannas, A.S., Arloth, J., Carrillo-Roa, T., Iurato, S., Roh, S., Ressler, K.J., et al. Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling. Genome Biol, 16, 2015, 266.
18. [18] Levine, M.E., Lu, A.T., Chen, B.H., Hernandez, D.G., Singleton, A.B., Ferrucci, L., et al. Menopause accelerates biological aging. Proc Natl Acad Sci U S A 113:33 (2016), 9327–9332.
19. [19] Horvath, S., Ritz, B.R., Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients. Aging (Albany NY) 7:12 (2015), 1130–1142.
20. [20] Levine, M.E., Hosgood, H.D., Chen, B., Absher, D., Assimes, T., Horvath, S., DNA methylation age of blood predicts future onset of lung cancer in the women's health initiative. Aging (Albany NY) 7:9 (2015), 690–700.
21. [21] Bingham, S., Riboli, E., Diet and cancer–the European prospective investigation into cancer and nutrition. Nat Rev Cancer 4:3 (2004), 206–215.
22. [22] Riboli, E., Hunt, K.J., Slimani, N., Ferrari, P., Norat, T., Fahey, M., et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 5:6B (2002), 1113–1124.
23. [23] Ambatipudi, S., Cuenin, C., Hernandez-Vargas, H., Ghantous, A., Calvez-Kelm, F.L., Kaaks, R., et al. Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study. Epigenomics 8:5 (2016), 599–618.
24. [24] Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol, 5(10), 2004, R80.
25. [25] Chen, Y.A., Lemire, M., Choufani, S., Butcher, D.T., Grafodatskaya, D., Zanke, B.W., et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8:2 (2013), 203–209.
26. [26] Teschendorff, A.E., Marabita, F., Lechner, M., Bartlett, T., Tegner, J., Gomez-Cabrero, D., et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 29:2 (2013), 189–196.
27. [27] Houseman, A.E., Accomando, P.W., Koestler, C.D., Christensen, C.B., Marsit, J.C., Nelson, H.H., et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinforma, 2012, 13.
28. [28] Horvath, S., Gurven, M., Levine, M.E., Trumble, B.C., Kaplan, H., Allayee, H., et al. An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease. Genome Biol, 17(1), 2016, 171.
29. [29] Esteller, M., Epigenetics in cancer. N Engl J Med 358:11 (2008), 1148–1159.
30. [30] Martin, M., Ancey, P.B., Cros, M.P., Durand, G., Le Calvez-Kelm, F., Hernandez-Vargas, H., et al. Dynamic imbalance between cancer cell subpopulations induced by transforming growth factor beta (TGF-beta) is associated with a DNA methylome switch. BMC Genomics, 15, 2014, 435.
31. [31] Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J.M., et al. High density DNA methylation array with single CpG site resolution. Genomics 98:4 (2011), 288–295.
32. [32] Irizarry, R.A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41:2 (2009), 178–186.
33. [33] Sandoval, J., Heyn, H., Moran, S., Serra-Musach, J., Pujana, M.A., Bibikova, M., et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6:6 (2011), 692–702.
34. [34] Blagosklonny, M.V., Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives. Aging (Albany NY) 2:5 (2010), 265–273.
35. [35] Horiuchi, S., Postmenopausal acceleration of age-related mortality increase. J Gerontol A Biol Sci Med Sci 52:1 (1997), B78–B92.
36. [36] Demetriou, C.A., Chen, J., Polidoro, S., van Veldhoven, K., Cuenin, C., Campanella, G., et al. Methylome analysis and epigenetic changes associated with menarcheal age. PLoS One, 8(11), 2013, e79391.
37. [37] Heyn, H., Carmona, F.J., Gomez, A., Ferreira, H.J., Bell, J.T., Sayols, S., et al. DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker. Carcinogenesis 34:1 (2013), 102–108.
38. [38] Severi, G., Southey, M.C., English, D.R., Jung, C.H., Lonie, A., McLean, C., et al. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer. Breast Cancer Res Treat 148:3 (2014), 665–673.
39. [39] Xu, X., Gammon, D.M., Hernandez-Vargas, H., Herceg, Z., Wetmur, G.J., Teitelbaum, L.S., et al. DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J 26 (2012), 2657–2666.
40. [40] Wallace, K., Grau, M.V., Levine, A.J., Shen, L., Hamdan, R., Chen, X., et al. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila) 3:12 (2010), 1552–1564.
41. [41] Kuchiba, A., Iwasaki, M., Ono, H., Kasuga, Y., Yokoyama, S., Onuma, H., et al. Global methylation levels in peripheral blood leukocyte DNA by LUMA and breast cancer: a case-control study in Japanese women. Br J Cancer 110:11 (2014), 2765–2771.
42. [42] van Veldhoven, K., Polidoro, S., Baglietto, L., Severi, G., Sacerdote, C., Panico, S., et al. Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clin Epigenetics, 7(1), 2015, 67.
43. [43] Issa, J.P., Aging, DNA methylation and cancer. Crit Rev Oncol Hematol 32:1 (1999), 31–43.
44. [44] Langevin, S.M., Pinney, S.M., Leung, Y.K., Ho, S.M., Does epigenetic drift contribute to age-related increases in breast cancer risk?. Epigenomics 6:4 (2014), 367–369.
45. [45] Issa, J.P., Aging and epigenetic drift: a vicious cycle. J Clin Invest 124:1 (2014), 24–29.
46. [46] Zheng, Y., Joyce, B.T., Colicino, E., Liu, L., Zhang, W., Dai, Q., et al. Blood epigenetic age may predict cancer incidence and mortality. EBioMedicine 5 (2016), 68–73.